SOPHiA GENETICS (SOPH) Asset Writedowns and Impairment (2024 - 2026)

SOPHiA GENETICS has disclosed Asset Writedowns and Impairment across 3 years of filings, most recently posting $10000.0 for Q2 2026.

• In Q2 2026, Asset Writedowns and Impairment fell 96.32% year-over-year to $10000.0; the TTM figure through Jun 2026 stood at -$155000.0 (up 34.6% YoY), while the FY2025 annual figure was $57000.0, up 110.9% from the prior year.
• Asset Writedowns and Impairment came in at $10000.0 for Q2 2026 at SOPHiA GENETICS, down from $30000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $272000.0 in Q2 2025 to a low of -$271000.0 in Q4 2024.
• Average Asset Writedowns and Impairment over 3 years is -$49000.0, with a median of -$5000.0 recorded in 2025.
• The largest YoY upside for Asset Writedowns and Impairment was 250.0% in 2026 against a maximum downside of 96.32% in 2026.
• Over 3 years, Asset Writedowns and Impairment stood at -$271000.0 in 2024, then soared by 123.62% to $64000.0 in 2025, then plunged by 84.38% to $10000.0 in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $10000.0 in Q2 2026, $30000.0 in Q1 2026, and $64000.0 in Q4 2025.